Skip to main content
Log in

Infections caused by multidrug-resistant bacteria high burden in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Nelson RE, et al. National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States. Clinical Infectious Diseases 72: S17-S26, 29 Jan 2021. Available from: URL: http://doi.org/10.1093/cid/ciaa1581

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Infections caused by multidrug-resistant bacteria high burden in the US. PharmacoEcon Outcomes News 872, 18 (2021). https://doi.org/10.1007/s40274-021-7491-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7491-8

Navigation